Nuveen Lifecycle Index 2045 Fund I (TLMHX)
38.10
-0.12
(-0.31%)
USD |
Nov 18 2026
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.18% | 10.07B | -- | 21.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -297.28M | 10.01% |
Basic Info
| Investment Strategy | |
| The Fund seeks high total return over time through a combination of capital appreciation and income. The Fund is a fund of funds that invests in the other funds of the Trust. The Fund invests in funds according to an asset allocation strategy designed for investors retiring/planning to retire within a few years of 2045. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | -- |
| Broad Asset Class | Allocation |
| Broad Category | Allocation |
| Global Peer Group | Target Maturity MA USD 2045 |
| Peer Group | Mixed-Asset Target 2045 Funds |
| Global Macro | Target Maturity |
| US Macro | Mixed-Assets Target Date Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth Funds |
| Fund Owner Firm Name | Nuveen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fund Flows
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of November 19, 2026.
Asset Allocation
As of September 30, 2026.
| Type | % Net |
|---|---|
| Cash | 0.09% |
| Stock | 82.72% |
| Bond | 16.24% |
| Convertible | 0.00% |
| Preferred | 0.29% |
| Other | 0.67% |
Top 8 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Nuveen Equity Index Fund W | 52.64% | 50.73 | -0.16% |
| Nuveen International Equity Index Fund W | 19.87% | 29.59 | -1.04% |
| Nuveen Bond Index Fund W | 12.03% | 9.35 | 0.21% |
| Nuveen Emerging Markets Equity Index Fund W | 11.37% | 15.03 | -0.40% |
| Nuveen International Aggregate Bond ETF | 3.01% | 24.39 | 0.02% |
| Nuveen High Yield Corporate Bond ETF | 0.98% | 23.74 | -0.02% |
|
Other Assets less Liabilities
|
0.22% | -- | -- |
|
USD Cash
|
-0.12% | -- | -- |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.09% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 100000.0 None |
| Minimum Subsequent Investment | 0.00 None |
TTM Distributions
| Type | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of October 31, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks high total return over time through a combination of capital appreciation and income. The Fund is a fund of funds that invests in the other funds of the Trust. The Fund invests in funds according to an asset allocation strategy designed for investors retiring/planning to retire within a few years of 2045. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | -- |
| Broad Asset Class | Allocation |
| Broad Category | Allocation |
| Global Peer Group | Target Maturity MA USD 2045 |
| Peer Group | Mixed-Asset Target 2045 Funds |
| Global Macro | Target Maturity |
| US Macro | Mixed-Assets Target Date Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth Funds |
| Fund Owner Firm Name | Nuveen |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (11-18-26) | 2.35% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 8 |
| Stock | |
| Weighted Average PE Ratio | 28.01 |
| Weighted Average Price to Sales Ratio | 7.240 |
| Weighted Average Price to Book Ratio | 8.662 |
| Weighted Median ROE | 67.23% |
| Weighted Median ROA | 15.29% |
| Return on Investment (TTM) | 22.92% |
| Earning Yield | 0.0509 |
| LT Debt / Shareholders Equity | 0.7354 |
| Number of Equity Holdings | 0 |
| Bond | |
| Yield to Maturity (9-30-26) | 4.96% |
| Effective Duration | -- |
| Average Coupon | 3.93% |
| Calculated Average Quality | 2.582 |
| Effective Maturity | 11.55 |
| Nominal Maturity | 11.62 |
| Number of Bond Holdings | 0 |
As of September 30, 2026
Growth Metrics
| EPS Growth (1Y) | 26.35% |
| EPS Growth (3Y) | 18.76% |
| EPS Growth (5Y) | 22.48% |
| Sales Growth (1Y) | 14.86% |
| Sales Growth (3Y) | 13.34% |
| Sales Growth (5Y) | 14.78% |
| Sales per Share Growth (1Y) | 22.69% |
| Sales per Share Growth (3Y) | 14.00% |
| Operating Cash Flow - Growth Rate (3Y) | 22.74% |
As of September 30, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:TLMHX", "name") |
| Broad Asset Class: =YCI("M:TLMHX", "broad_asset_class") |
| Broad Category: =YCI("M:TLMHX", "broad_category_group") |
| Prospectus Objective: =YCI("M:TLMHX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |